ChenL., ChoiJ., ChoiY. & HennigB. & ToborekM. (2011). HIV-1 TAT-induced cerebrovascular toxicity is
enhanced in mice with amyloid deposits. Neurobiology of
Aging, July 14. [Epub ahead of print].
2.
JonesS., ChristisonR., BundellK., VoyceC., BrockbankS. & NewhamP. (2005). Characterisation of cell-penetrating
peptide-mediated peptide delivery. British Journal of
Pharmacology, 45(8), 1093–1102.
3.
MinD., KimH., ParkL., KimT., HwangS. & KimM. (2012). Amelioration of diabetic neuropathy by TAT-mediated
enhanced delivery of metallothionein and SOD. Endocrinology, 53(1), 81–91.
4.
OgawaT., OnoS., IchikawaT., ArimitsuS., OnodaK. & TokunagaK. (2009). Protein transduction method for cerebrovascular
disorders. Acta Medica Okayama, 63(1), 1–7.
5.
ParkL., MinD., KimH., ChungH., LeeC. & ParkI. (2011). TAT-enhanced delivery of metallothionein can
partially prevent the development of diabetes. Free Radical
Biology & Medicine, 51(9), 1666–1674.
6.
Sunavala-DossabhoyG., PalaniyandiS., RichardsonC., De BenedettiA. & SchrottL. & CalditoG. (2012). TAT-mediated delivery of tousled protein to salivary
glands protects against radiation-induced hypofunction. International Journal of Radiation Oncology, Biology, Physics, January 26. [Epub ahead of print].
7.
YanH., LiuN., ZhaoZ., ZhangX., XuH. & ShaoB. (2012). Expression and purification of human TAT-p53 fusion
protein in Pichia pastoris and its influence on HepG2 cell apoptosis. Biotechnology Letters, March 17. [Epub ahead of print].
8.
YoshikawaT., SugitaT., MukaiY., AbeY., NakagawaS. & KamadaH. (2009). The augmentation of intracellular delivery of
peptide therapeutics by artificial protein transduction domains. Biomaterials, 30(19), 3318–3323.
9.
ZhaoY., WuS., WuJ., JiaP., GaoS. & YanX. (2011a). Introduction of hypoxia targeting p53 fusion
protein for the selective therapy of non-small cell lung cancer. Cancer Biology & Therapy, 11(1), 95–107.
10.
ZhaoJ., RedellJ. & MooreA. & DashP. (2011b). A novel strategy to activate cytoprotective genes
in the injured brain. Biochemical and Biophysical Research
Communications, 407(3), 501–506.